These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1000 related articles for article (PubMed ID: 25029122)
21. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572 [TBL] [Abstract][Full Text] [Related]
22. Precursor of prostate-specific antigen expression in prostatic intraepithelial neoplasia and adenocarcinoma: a study of 90 cases. Hull D; Ma J; Singh H; Hossain D; Qian J; Bostwick DG BJU Int; 2009 Oct; 104(7):915-8. PubMed ID: 19388995 [TBL] [Abstract][Full Text] [Related]
23. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Tavora F; Epstein JI Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142 [TBL] [Abstract][Full Text] [Related]
24. Evaluation of contemporary prostate and urothelial lineage biomarkers in a consecutive cohort of poorly differentiated bladder neck carcinomas. Mohanty SK; Smith SC; Chang E; Luthringer DJ; Gown AM; Aron M; Amin MB Am J Clin Pathol; 2014 Aug; 142(2):173-83. PubMed ID: 25015857 [TBL] [Abstract][Full Text] [Related]
25. Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens. Browne TJ; Hirsch MS; Brodsky G; Welch WR; Loda MF; Rubin MA Hum Pathol; 2004 Dec; 35(12):1462-8. PubMed ID: 15619204 [TBL] [Abstract][Full Text] [Related]
26. Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells. Weinstein MH; Signoretti S; Loda M Mod Pathol; 2002 Dec; 15(12):1302-8. PubMed ID: 12481011 [TBL] [Abstract][Full Text] [Related]
27. Immunocytochemical study of urine cytological preparations from secondary prostatic adenocarcinoma involving the urinary bladder. Mai KT; Ahmed I; Robertson SJ; Belanger EC; Veinot JP; Islam S Diagn Cytopathol; 2008 Oct; 36(10):715-20. PubMed ID: 18773445 [TBL] [Abstract][Full Text] [Related]
28. Prostatic adenocarcinoma in colorectal biopsy: clinical and pathologic features. Lane Z; Epstein JI; Ayub S; Netto GJ Hum Pathol; 2008 Apr; 39(4):543-9. PubMed ID: 18234278 [TBL] [Abstract][Full Text] [Related]
29. Small cell carcinoma of the prostate. A morphologic and immunohistochemical study of 95 cases. Wang W; Epstein JI Am J Surg Pathol; 2008 Jan; 32(1):65-71. PubMed ID: 18162772 [TBL] [Abstract][Full Text] [Related]
30. Differential Immunohistochemical Profiles for Distinguishing Prostate Carcinoma and Urothelial Carcinoma. Oh WJ; Chung AM; Kim JS; Han JH; Hong SH; Lee JY; Choi YJ J Pathol Transl Med; 2016 Sep; 50(5):345-54. PubMed ID: 27498545 [TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical expression of prostatic antigens in adenocarcinoma and villous adenoma of the urinary bladder. Lane Z; Hansel DE; Epstein JI Am J Surg Pathol; 2008 Sep; 32(9):1322-6. PubMed ID: 18670358 [TBL] [Abstract][Full Text] [Related]
32. Is atypical adenomatous hyperplasia of the prostate a precursor lesion? Zhang C; Montironi R; MacLennan GT; Lopez-Beltran A; Li Y; Tan PH; Wang M; Zhang S; Iczkowski KA; Cheng L Prostate; 2011 Dec; 71(16):1746-51. PubMed ID: 21480308 [TBL] [Abstract][Full Text] [Related]
33. Comparison of annexin II, p63 and alpha-methylacyl-CoA racemase immunoreactivity in prostatic tissue: a tissue microarray study. Stewart J; Fleshner N; Cole H; Sweet J J Clin Pathol; 2007 Jul; 60(7):773-80. PubMed ID: 16916997 [TBL] [Abstract][Full Text] [Related]
34. Diagnostic utility of p63 and α-methyl acyl Co A racemase in resolving suspicious foci in prostatic needle biopsy and transurethral resection of prostate specimens. Singh V; Manu V; Malik A; Dutta V; Mani NS; Patrikar S J Cancer Res Ther; 2014; 10(3):686-92. PubMed ID: 25313761 [TBL] [Abstract][Full Text] [Related]
35. The diagnostic use of ERG in resolving an "atypical glands suspicious for cancer" diagnosis in prostate biopsies beyond that provided by basal cell and α-methylacyl-CoA-racemase markers. Shah RB; Tadros Y; Brummell B; Zhou M Hum Pathol; 2013 May; 44(5):786-94. PubMed ID: 23158212 [TBL] [Abstract][Full Text] [Related]
36. The value of triple antibody (34βE12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins. Daoud NA; Li G; Evans AJ; van der Kwast TH J Clin Pathol; 2012 May; 65(5):437-40. PubMed ID: 22294716 [TBL] [Abstract][Full Text] [Related]
37. Utility of p63 and high molecular weight cytokeratin in the distinction between urothelial carcinoma with prostatic stromal invasion and urothelial carcinoma with colonisation of prostatic ducts and acini. Chastain EC; Oliva IV; Osunkoya AO Pathology; 2012 Apr; 44(3):199-203. PubMed ID: 22406481 [TBL] [Abstract][Full Text] [Related]
38. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Epstein JI; Amin MB; Reuter VE; Humphrey PA Am J Surg Pathol; 2017 Apr; 41(4):e1-e7. PubMed ID: 28177964 [TBL] [Abstract][Full Text] [Related]
39. Can basal cells be seen in adenocarcinoma of the prostate?: an immunohistochemical study using high molecular weight cytokeratin (clone 34betaE12) antibody. Oliai BR; Kahane H; Epstein JI Am J Surg Pathol; 2002 Sep; 26(9):1151-60. PubMed ID: 12218571 [TBL] [Abstract][Full Text] [Related]
40. Expression of CDX2 in benign tissue and adenocarcinoma of the prostate. Herawi M; De Marzo AM; Kristiansen G; Epstein JI Hum Pathol; 2007 Jan; 38(1):72-8. PubMed ID: 16949907 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]